Clover Health Investments, Corp. reports results for the quarter ended September 30 - Earnings Summary

• Clover Health Investments, Corp. reported quarterly adjusted earnings of 1 cent​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -5 cents. The mean expectation of four analysts for the quarter was for breakeven results per share. Wall Street expected results to range from -1 cents to 1 cents per share.

• Revenue rose 52.9% to $759.30 million from a year ago; analysts expected $738.42 million.

• Clover Health Investments, Corp.'s reported EPS for the quarter was 1 cent​.

• The company reported quarterly net income of $6.44 million.

• Clover Health Investments, Corp. shares had fallen by 0.5% this quarter and gained 82.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 24.9% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the managed healthcare peer group is also "buy"

• Wall Street's median 12-month price target for Clover Health Investments, Corp. is $5.25, about 18.3% above its last closing price of $4.29

This summary was machine generated from LSEG data November 4 at 11:24 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)